Adenoviral Vector Codifying for TNF as a Co-Adjuvant Therapy against Multi-Drug-Resistant Tuberculosis

Adenoviral Vector Codifying for TNF as a Co-Adjuvant Therapy against Multi-Drug-Resistant Tuberculosis

<i>Mycobacterium tuberculosis</i> is the main causal agent of pulmonary tuberculosis (TB); the treatment of this disease is long and involves a mix of at least four different antibiotics that frequently lead to abandonment, favoring the surge of drug-resistant mycobacteria (MDR-TB), whos...

Full description

Bibliographic Details
Main Authors: Sujhey Hernández-Bazán, Dulce Mata-Espinosa, Octavio Ramos-Espinosa, Vasti Lozano-Ordaz, Jorge Barrios-Payán, Fernando López-Casillas, Rogelio Hernández-Pando
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Microorganisms
Subjects:
Tuberculosis
gene therapy
adenoviral vectors
multi-drug resistance
Tumor Necrosis Factor
Online Access:https://www.mdpi.com/2076-2607/11/12/2934

Internet

https://www.mdpi.com/2076-2607/11/12/2934

Similar Items